Mankind Pharma forays into critical care segment

Mankind Pharma forays into critical care segment

AgenciesUpdated: Wednesday, January 19, 2022, 08:03 PM IST
article-image
The new division Saviour Mankind has commenced operation, with a product range that includes anti-infectives and medications for stroke and trauma management. |

Mankind Pharma stated that it has forayed into the critical care segment in the country with the launch of a dedicated division.

The new division Saviour Mankind has commenced operation, with a product range that includes anti-infectives and medications for stroke and trauma management.

''Through this division, we hope to partner with doctors in saving the lives of critically ill patients," stated Mankind Pharma CEO Sheetal Arora.

With the launch, Mankind Pharma added that it aspires to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines.

(With inputs from PTI)

RECENT STORIES

Coromandel International Q4 Profit Falls 33% To ₹164 Cr On Lower Income

Coromandel International Q4 Profit Falls 33% To ₹164 Cr On Lower Income

PM SVANidhi: Centre Paid ₹147.82 Crore In Interest Subsidy On Loans

PM SVANidhi: Centre Paid ₹147.82 Crore In Interest Subsidy On Loans

'It Levels The Playing Field': After Old Video, Nikhil Kamath's Article Supporting Inheritance Tax...

'It Levels The Playing Field': After Old Video, Nikhil Kamath's Article Supporting Inheritance Tax...

Rupee On The Rise: Expert Forecasts Appreciation To ₹82-82.50 In FY25

Rupee On The Rise: Expert Forecasts Appreciation To ₹82-82.50 In FY25

Tech Mahindra Net Profit Tanks 41% To ₹661 Cr In Q4FY24

Tech Mahindra Net Profit Tanks 41% To ₹661 Cr In Q4FY24